# Blood transfusion

**Blood transfusion** .

Risks: Massive transfusion (blood volume replaced in &lt;24h): ↓ Temp, ↓
pH, ↓ coagulation factors, ↓ Ca++, ↑K+.

In order of morbidity/mortality:

1. TRALI

2. Immediate haemolytic reactions: immune/non-immune - Intravascular
haemolysis: fever, urticaria, hypotension, DIC.

3. Delayed haemolytic reactions 7-21 days, extravascular haemolysis, ↓
Hb.

4. Fever reaction. Common but harmless.

5. Allergy. Urticaria, fever. Anaphylaxis rare.

6. Infection:

Bacterial

\- RCC (4°C) Gram -ve, eg. Yersinia enterocolitica; Pseudomonas

\- Plts (20°C) Gram +ve, eg. Staph. Epidermidis, Staph. Aureus,
Bacillus.

Viral

\- HBV

\- HCV: 1 in 32 million

\- HIV: 1 in 5 million

\- CMV

Prion

7. GvHD. Pre-leucodepletion. Mortality 90%.

8. Immunosuppression - used therapeutically to prevent transplant
rejection.

\[Maxwell, M.J. et al. *Contin Educ Anaesth Crit Care Pain* **6** ,
225-229(2006).\]
